Within 24 hours of exosome treatment, the COVID patient with ARDS showed decreased requirement for oxygen and pressure and within 5 days, he was being extubated.
To watch these seven related videos interviewing experts in regenerative medicine with a focus on exosomes and their many uses.
DISCLAIMER: This website is for educational purposes only and is not for advertising. Telomerase activators and nanovesicles are not FDA-approved to prevent or treat any disease and anecdotes are not scientific proof of efficacy. All patients were treated in the context of a fully informed and legally-protected patient physician relationship.
Required fields
© 2020 Recharge Biomedical
Exosomes and TA-65 are not FDA-approved to prevent or treat any illness
